| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/15/2004 | EP1456366A1 Novel alkali protease formed by bacillus gibsonii (dsm 14393) and washing and cleaning agents containing said novel alkali protease |
| 09/15/2004 | EP1456365A2 Protein modification and maintenance molecules |
| 09/15/2004 | EP1456363A1 Alleles of the siga gene from coryneform bacteria |
| 09/15/2004 | EP1456360A2 Methods and composition for the production of orthoganal trna-aminoacyltrna synthetase pairs |
| 09/15/2004 | EP1456357A2 Pluripotent embryonic-like stem cells derived from teeth and uses thereof |
| 09/15/2004 | EP1456356A2 Method of producing human beta cell lines |
| 09/15/2004 | EP1456349A2 Expression system |
| 09/15/2004 | EP1456348A1 Saccharomyces-cerevisiae yeast strain with stable integration and expression of the nucleic acid sequence for a heterologous potassium ion channel |
| 09/15/2004 | EP1456347A2 Antibodies that immunospecifically bind to blys |
| 09/15/2004 | EP1456346A2 Novel ecdysone receptor/invertebrate retinoid x receptor-based inducible gene expression system |
| 09/15/2004 | EP1456345A2 Apparatus and method for electroporation of biological samples |
| 09/15/2004 | EP1456240A2 Target specific screening and its use for identifying target binders |
| 09/15/2004 | EP1456239A2 Hybrid proteins with neuregulin heparin-binding domain for targeting to heparan sulfate proteoglycans |
| 09/15/2004 | EP1456238A2 Production of f(ab')2 fragments in mammalian cells |
| 09/15/2004 | EP1456237A2 Method for cloning of variable domain sequences |
| 09/15/2004 | EP1456235A2 Factor viii c2 domain variants |
| 09/15/2004 | EP1456234A2 Epitope regions of a thyrotrophin (tsh) receptor, uses thereof and antibodies thereto |
| 09/15/2004 | EP1456232A2 Genes encoding for membrane synthesis and membrane transport proteins |
| 09/15/2004 | EP1456231A2 Streptococcus antigens |
| 09/15/2004 | EP1456230A2 Flavivirus ns1 subunit vaccine |
| 09/15/2004 | EP1456223A2 Rapidly maturing fluorescent proteins and methods for using the same |
| 09/15/2004 | EP1456222A2 Non-human primate fc receptors and methods of use |
| 09/15/2004 | EP1456221A2 Nucleic acid constructs including a novel t-cell active promoter, and pharmaceutical compositions and methods utilizing same for regulating t-cell mediated immune response |
| 09/15/2004 | EP1456220A2 Thermus thermophilus nucleic acid polymerases |
| 09/15/2004 | EP1456130A1 Forming and modifying dielctrically-engineered microparticles |
| 09/15/2004 | EP1455949A1 Centrifugal spectrometer |
| 09/15/2004 | EP1455841A2 Osteopontin-related compositions and methods |
| 09/15/2004 | EP1455840A2 Treatment of human cancer with adenoviral vector expressing tnf-alpha |
| 09/15/2004 | EP1455830A1 Selective anesthetic agents and methods of identifying the same |
| 09/15/2004 | EP1455813A2 Pharmaceutical composition of interferon gamma or pirfenidone with molecular diagnostics for the improved treatment of interstitial lung disease |
| 09/15/2004 | EP1455765A2 Use of protease-activated receptor-2 inhibitor in the manufacture of a medicament for treating delayed hypersensitivity |
| 09/15/2004 | EP1455700A2 Methods and compositions related to irm compounds and toll-like receptor pathways |
| 09/15/2004 | EP1455580A2 METHODS AND COMPOSITIONS FOR TREATING HEMATOLOGICAL DISORDERS USING 252, 304, 19870, 14717, 9941, 19310 and 17832 |
| 09/15/2004 | EP1455573A1 Method of preparing eggs for nuclear transfer and uses thereof |
| 09/15/2004 | EP1455568A2 Method for transformation of mono- and di- cotyledonous plants using meristematic tissue and nodal callus from dycotiledonous plants |
| 09/15/2004 | EP1418808A4 Imaging marker transgenes |
| 09/15/2004 | EP1390381A4 Lipid metabolism regulators in plants |
| 09/15/2004 | EP1386154A4 Automated methods of detecting receptor activity |
| 09/15/2004 | EP1386006A4 Methods for nucleic acid manipulation |
| 09/15/2004 | EP1294881B1 Control of metabolism with compositions of the human 2-oxoglutarate carrier |
| 09/15/2004 | EP1290225A4 Method of producing a dna library using positional amplification |
| 09/15/2004 | EP1246942A4 Ferrofluid based arrays |
| 09/15/2004 | EP1192263B1 Pichia methanolica glyceraldehyde-3-phosphate dehydrogenase 1 promoter and terminator |
| 09/15/2004 | EP1190254B1 Attachment of biomolecule to a polymeric solid support by cycloaddition of a linker |
| 09/15/2004 | EP1181559B1 System and method for filling a substrate with a liquid sample |
| 09/15/2004 | EP1173547A4 Dwf4 polynucleotides, polypeptides and uses thereof |
| 09/15/2004 | EP1152821B1 Method for producing addressed ligand matrixes on a support |
| 09/15/2004 | EP1144616B1 Method for producing antibody fragments |
| 09/15/2004 | EP1123111B1 Modulation of dna methyltransferase expression by combination therapy |
| 09/15/2004 | EP1115736A4 Detection of human herpes virus 6 (hhv6) |
| 09/15/2004 | EP1076549B1 Use of metalloprotinease inhibitors for inducing and/or stimulating growth of hair or hairs and/or for slowing down their loss |
| 09/15/2004 | EP1064305B1 Recombinant virus |
| 09/15/2004 | EP1032708A4 Nucleic acid ligands of tissue target |
| 09/15/2004 | EP1032705A4 Probe arrays and methods of using probe arrays for distinguishing dna |
| 09/15/2004 | EP1023319B1 Immuno-reactive peptide ctl epitopes of human cytomegalovirus |
| 09/15/2004 | EP1007095B1 CHIMERIC TOXINS COMPRISING GnRH FOR TARGETED THERAPY |
| 09/15/2004 | EP0942985B1 Broad-spectrum delta-endotoxins |
| 09/15/2004 | EP0877760B1 Mhc complexes and uses thereof |
| 09/15/2004 | EP0833919B1 Type f botulinum toxin and use thereof |
| 09/15/2004 | EP0824540B1 Nucleic acid ligands of tissue target |
| 09/15/2004 | EP0788542B1 Fae1 genes and their uses |
| 09/15/2004 | EP0783579B1 Antigenic fragment of the tagA gene and methods for detecting predisposition to peptic ulceration and gastric carcinoma |
| 09/15/2004 | EP0740553B1 Monoclonal antibodies to antigens expressed by hematopoietic facilitatory cells |
| 09/15/2004 | EP0707644B1 Use of pharmaceutical compositions for the treatment of neurodegenerative diseases |
| 09/15/2004 | EP0678523B1 Recombinant anti-hiv antibody and preparation thereof |
| 09/15/2004 | EP0647275B1 Cloning and expression of gonadotropin-releasing hormone receptor |
| 09/15/2004 | EP0624195B1 Novel biologically active polypeptides, preparation thereof and pharmaceutical composition containing said polypeptides |
| 09/15/2004 | CN1529760A Process for enhanced production of pantothenate |
| 09/15/2004 | CN1529759A Modular transfection system |
| 09/15/2004 | CN1529758A Novel expression vectors and uses thereof |
| 09/15/2004 | CN1529757A Fusion Protein for secretion of protein of interest in supernatant of bacterial culture |
| 09/15/2004 | CN1529756A Steroselective preparation of cyclic L-amino acids |
| 09/15/2004 | CN1529755A Novel bacterial phytases and method for producing same |
| 09/15/2004 | CN1529754A Variable region of monoclonal antibody against HBV S-surface antigene and gene encoding same |
| 09/15/2004 | CN1529753A Disease-associated protein |
| 09/15/2004 | CN1529752A Alpha-amylase mutants with altered properties |
| 09/15/2004 | CN1529714A Modified interfron alpha with reduced immunogenicity |
| 09/15/2004 | CN1529713A Compositions and methods for therapy and diagnosis of ovarian cancer |
| 09/15/2004 | CN1529712A Process for preparing dipeptide, Peptide synthase to be used therein and process for producing peptide synthase |
| 09/15/2004 | CN1529710A Recombinant protective protein from streptococcus pneumoniae |
| 09/15/2004 | CN1529619A Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enbancing agents |
| 09/15/2004 | CN1529613A Method for using nervous thread proteins to treat tumors and other conditions requiring removal of destruction of cells |
| 09/15/2004 | CN1529607A Treatment of T cell disorders |
| 09/15/2004 | CN1528911A Phycoerythrin beta and alpha subunit gene promotor, and preparing method and use thereof |
| 09/15/2004 | CN1528904A Novel Plastid-targeting nucleic acid sequence, novel beta-amylase sequence and stimulus responsive promptor and uses thereof |
| 09/15/2004 | CN1528903A Human alphal 1-thymic peptide gene multicopy directional cloning and high-efficiency expression |
| 09/15/2004 | CN1528902A Method for homologous recombining by using spirulina and expressing human gene |
| 09/15/2004 | CN1528901A Chinese cabbage cold-related transcription factor protein coding sequence |
| 09/15/2004 | CN1528900A Chinese cabbage cold-related protein coding sequence |
| 09/15/2004 | CN1528899A Chinese cabbage phtosynthesis efficiency-increasing protein coding sequence |
| 09/15/2004 | CN1528898A Pakchoi mater stress protein coding sequence |
| 09/15/2004 | CN1528897A Cabbage type rape cold and salt related protein coding sequence |
| 09/15/2004 | CN1528896A Cabbage water stress related protein coding sequence |
| 09/15/2004 | CN1528895A Cabbage type rape drought-resistant salinity-tolerant transcription factor BnHB6 protein coding seuquence |
| 09/15/2004 | CN1528894A Long-acting reconbinant tissue factor channel inhibitor and preparing method thereof |
| 09/15/2004 | CN1528893A Designing artificial synthetic thymic hormone alphal gene sequence according to phyto preference codon |
| 09/15/2004 | CN1528892A Artrospira spirulina protein gene promotor and preparing method thereof |
| 09/15/2004 | CN1528891A Baciallus thuringiensis engineering bacterium Go33A and preparing method thereof |
| 09/15/2004 | CN1528889A Chinese cabbage 9-cis-carotene epoxide dioxygen zymoprotein coding sequence |
| 09/15/2004 | CN1528888A Epidermal staphylococcal tryptophanyl-tRNA synthetase and its use in screening drugs |